Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| May 17, 2026 | BlueCross BlueShield of Tennessee | Measurement of Exhaled Nitric Oxide and Exhaled Breath Condensate in the Diagnosis and Management of Asthma and Other Respiratory Disorders | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Digital Breast Tomosynthesis (3D Mammogram) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Breast Reconstructive and Symmetry Surgery Following Mastectomy | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Breast Implant Removal | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Breast Cancer Gene Expression Assays | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Breast Augmentation / Mammaplasty (Non-Cancerous) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Electronic Brachytherapy for Non-Melanoma Skin Cancer | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Bortezomib (Velcade; Bortezomib, Boruzu) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Blinatumomab (Blincyto) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Zenocutuzumab-zbco (Bizengri) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Plugs for Anal Fistula Repair | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Vertebral Fracture Assessment with Densitometry or Biomechanical Computed Tomography | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Cardiac Hemodynamic Monitoring for the Management of Heart Failure in the Outpatient Setting | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Bioidentical Compounded Hormone Therapy | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Biofeedback and Neurofeedback | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Bioimpedance Devices for Detection of Lymphedema | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Bevacizumab Products (Avastin; Mvasi ; Zirabev; Alymsys; Vegzelma, Avzivi, Jobevne) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Betibeglogene autotemcel (Zynteglo) (Intravenous) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Inotuzumab Ozogamicin (Besponsa) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Beremagene Geperpavec-svdt (Vyjuvek) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | C1 Esterase Inhibitor (Human) - Berinert | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Fidanacogene Elaparvovec-dzkt (Beqvez) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Brolucizumab-dbll (Beovu) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Benralizumab (Fasenra) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Bendamustine Products (Treanda, Belrapzo, Bendeka, Vivimusta, Bendamustine) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Belimumab (Benlysta) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Belinostat(Beleodaq) | Criteria changed |
| May 17, 2026 | BCBS Oklahoma | Wireless Capsule Endoscopy for Gastrointestinal (GI) Disorders | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Belantamab Mafodotin-blmf (Blenrep) | Criteria changed |
| May 17, 2026 | BCBS Oklahoma | Wilate | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Baroreflex Stimulation Devices | Criteria changed |
| May 17, 2026 | BCBS Oklahoma | Wheelchairs and Accessories | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Balloon Dilation of the Eustachian Tube | Criteria changed |
| May 17, 2026 | BCBS Oklahoma | Vutrisiran (Amvuttra) and Patisiran (Onpattro) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Azacitidine (Vidaza) | Criteria changed |
| May 17, 2026 | BCBS Oklahoma | Viscocanalostomy and Canaloplasty | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Axicabtagene Ciloleucel (Yescarta) | Criteria changed |
| May 17, 2026 | BCBS Oklahoma | Vestibular Function Testing | Criteria changed |
| May 17, 2026 | BCBS Oklahoma | Vertical Expandable Prosthetic Titanium Rib | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Axial Lumbosacral Interbody Fusion | Criteria changed |
| May 17, 2026 | BCBS Oklahoma | Vertebral Axial Decompression | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Axatilimab-csfr (Niktimvo) | Criteria changed |
| May 17, 2026 | BCBS Oklahoma | Ventricular Assist Devices and Total Artificial Hearts | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Avelumab (Bavencio) | Criteria changed |
| May 17, 2026 | BCBS Oklahoma | Vedolizumab | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Avalglucosidase Alfa-ngpt (Nexviazyme) | Criteria changed |
| May 17, 2026 | BCBS Oklahoma | Varicose Vein Management | Criteria changed |
| May 17, 2026 | BCBS Oklahoma | Valoctocogene Roxaparvovec-rvox | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Autonomic Nervous System Testing | Criteria changed |
| May 17, 2026 | BCBS Oklahoma | Vagus Nerve Stimulation (VNS) | Criteria changed |